ID   TOLIP_HUMAN             Reviewed;         274 AA.
AC   Q9H0E2; B3KXC6; Q9H9E6; Q9UJ69;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   18-JUN-2025, entry version 202.
DE   RecName: Full=Toll-interacting protein;
GN   Name=TOLLIP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND SUBUNIT.
RX   PubMed=10854325; DOI=10.1038/35014038;
RA   Burns K., Clatworthy J., Martin L., Martinon F., Plumpton C., Maschera B.,
RA   Lewis A., Ray K., Tschopp J., Volpe F.;
RT   "Tollip, a new component of the IL-1R1 pathway, links IRAK to the IL-1
RT   receptor.";
RL   Nat. Cell Biol. 2:346-351(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 34-274 (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBUNIT, AND INTERACTION WITH TLR2 AND TLR4.
RX   PubMed=11751856; DOI=10.1074/jbc.m109537200;
RA   Zhang G., Ghosh S.;
RT   "Negative regulation of Toll-like receptor-mediated signaling by Tollip.";
RL   J. Biol. Chem. 277:7059-7065(2002).
RN   [7]
RP   INTERACTION WITH TOM1 AND UBIQUITIN.
RX   PubMed=14563850; DOI=10.1074/jbc.m306740200;
RA   Yamakami M., Yoshimori T., Yokosawa H.;
RT   "Tom1, a VHS domain-containing protein, interacts with tollip, ubiquitin,
RT   and clathrin.";
RL   J. Biol. Chem. 278:52865-52872(2003).
RN   [8]
RP   INTERACTION WITH TOM1L2.
RX   PubMed=16412388; DOI=10.1016/j.bbrc.2005.12.156;
RA   Katoh Y., Imakagura H., Futatsumori M., Nakayama K.;
RT   "Recruitment of clathrin onto endosomes by the Tom1-Tollip complex.";
RL   Biochem. Biophys. Res. Commun. 341:143-149(2006).
RN   [9]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH TOM1, INTERACTION WITH TOM1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15047686; DOI=10.1074/jbc.m400059200;
RA   Katoh Y., Shiba Y., Mitsuhashi H., Yanagida Y., Takatsu H., Nakayama K.;
RT   "Tollip and Tom1 form a complex and recruit ubiquitin-conjugated proteins
RT   onto early endosomes.";
RL   J. Biol. Chem. 279:24435-24443(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   INTERACTION WITH ATG8 FAMILY PROTEINS AND UBIQUITIN, DOMAIN, AND FUNCTION.
RX   PubMed=25042851; DOI=10.1016/j.cell.2014.05.048;
RA   Lu K., Psakhye I., Jentsch S.;
RT   "Autophagic clearance of PolyQ proteins mediated by ubiquitin-Atg8 adaptors
RT   of the conserved CUET protein family.";
RL   Cell 158:549-563(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   FUNCTION, INTERACTION WITH TOM1, SUBCELLULAR LOCATION, DOMAIN, AND
RP   MUTAGENESIS OF ARG-9; VAL-12; ASP-20; PHE-21 AND ARG-23.
RX   PubMed=26320582; DOI=10.1016/j.str.2015.07.017;
RA   Xiao S., Brannon M.K., Zhao X., Fread K.I., Ellena J.F., Bushweller J.H.,
RA   Finkielstein C.V., Armstrong G.S., Capelluto D.G.S.;
RT   "Tom1 Modulates Binding of Tollip to Phosphatidylinositol 3-Phosphate via a
RT   Coupled Folding and Binding Mechanism.";
RL   Structure 23:1910-1920(2015).
RN   [15]
RP   INTERACTION WITH TOM1 AND LRBA, AND SUBCELLULAR LOCATION.
RX   PubMed=31263572; DOI=10.1038/s41525-019-0088-5;
RA   Keskitalo S., Haapaniemi E.M., Glumoff V., Liu X., Lehtinen V., Fogarty C.,
RA   Rajala H., Chiang S.C., Mustjoki S., Kovanen P., Lohi J., Bryceson Y.T.,
RA   Seppaenen M., Kere J., Heiskanen K., Varjosalo M.;
RT   "Dominant TOM1 mutation associated with combined immunodeficiency and
RT   autoimmune disease.";
RL   NPJ Genom. Med. 4:14-14(2019).
RN   [16]
RP   STRUCTURE BY NMR OF 229-274.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of CUE domain in the C-terminal of human Toll-
RT   interacting protein (TOLLIP).";
RL   Submitted (NOV-2004) to the PDB data bank.
RN   [17]
RP   VARIANT ASN-161.
RX   PubMed=26282398; DOI=10.1186/s13023-015-0316-8;
RA   Dahmani M., Ammar-Khodja F., Bonnet C., Lefevre G.M., Hardelin J.P.,
RA   Ibrahim H., Mallek Z., Petit C.;
RT   "EPS8L2 is a new causal gene for childhood onset autosomal recessive
RT   progressive hearing loss.";
RL   Orphanet J. Rare Dis. 10:96-96(2015).
RN   [18]
RP   INTERACTION WITH ZNF268.
RX   PubMed=37926288; DOI=10.1016/j.jbc.2023.105428;
RA   Liu Y., Yin W., Zeng X., Fan J., Liu C., Gao M., Huang Z., Sun G., Guo M.;
RT   "TBK1-stabilized ZNF268a recruits SETD4 to methylate TBK1 for efficient
RT   interferon signaling.";
RL   J. Biol. Chem. 299:105428-105428(2023).
CC   -!- FUNCTION: Component of the signaling pathway of IL-1 and Toll-like
CC       receptors (PubMed:10854325, PubMed:11751856). Inhibits cell activation
CC       by microbial products. Recruits IRAK1 to the IL-1 receptor complex
CC       (PubMed:10854325). Inhibits IRAK1 phosphorylation and kinase activity
CC       (PubMed:11751856). Connects the ubiquitin pathway to autophagy by
CC       functioning as a ubiquitin-ATG8 family adapter and thus mediating
CC       autophagic clearance of ubiquitin conjugates (PubMed:25042851). The
CC       TOLLIP-dependent selective autophagy pathway plays an important role in
CC       clearance of cytotoxic polyQ proteins aggregates (PubMed:25042851). In
CC       a complex with TOM1, recruits ubiquitin-conjugated proteins onto early
CC       endosomes (PubMed:15047686). Binds to phosphatidylinositol 3-phosphate
CC       (PtdIns(3)P) (PubMed:26320582). {ECO:0000269|PubMed:10854325,
CC       ECO:0000269|PubMed:11751856, ECO:0000269|PubMed:15047686,
CC       ECO:0000269|PubMed:25042851, ECO:0000269|PubMed:26320582}.
CC   -!- SUBUNIT: Oligomerizes (PubMed:11751856). Interacts (via C-terminus)
CC       with TLR2 and the TLR4-MD2 complex (PubMed:11751856). Exists as complex
CC       with IRAK1 in unstimulated cells (PubMed:10854325). Upon IL-1
CC       signaling, binds to the activated IL-1 receptor complex containing IL-
CC       1RI, IL-1RacP and the adapter protein MyD88, where it interacts with
CC       the TIR domain of IL-1RacP (PubMed:10854325). MyD88 then triggers IRAK1
CC       autophosphorylation, which in turn leads to the dissociation of IRAK1
CC       from TOLLIP and IL-1RAcP (PubMed:10854325). Found in a complex with
CC       TOM1; interacts (via N-terminus) with TOM1 (via GAT domain); the
CC       interactions leads to TOM1-recruitment to endosomes and inhibition of
CC       TOLLIP binding to PtdIns(3)P (PubMed:14563850, PubMed:15047686,
CC       PubMed:26320582, PubMed:31263572). Interacts with TOM1L2
CC       (PubMed:16412388). Interacts with ATG8 family proteins (via AIM motifs)
CC       (PubMed:25042851). Interacts (via CUE domain) with ubiquitin
CC       (PubMed:14563850, PubMed:25042851). Interacts with LRBA
CC       (PubMed:31263572). Interacts with ZNF268; this interaction leads to
CC       degradation by Tollip-mediated selective autophagy system
CC       (PubMed:37926288). {ECO:0000269|PubMed:10854325,
CC       ECO:0000269|PubMed:11751856, ECO:0000269|PubMed:14563850,
CC       ECO:0000269|PubMed:15047686, ECO:0000269|PubMed:16412388,
CC       ECO:0000269|PubMed:25042851, ECO:0000269|PubMed:26320582,
CC       ECO:0000269|PubMed:31263572, ECO:0000269|PubMed:37926288}.
CC   -!- INTERACTION:
CC       Q9H0E2; Q5BKX5-3: ACTMAP; NbExp=3; IntAct=EBI-74615, EBI-11976299;
CC       Q9H0E2; P35609: ACTN2; NbExp=3; IntAct=EBI-74615, EBI-77797;
CC       Q9H0E2; Q96B67: ARRDC3; NbExp=3; IntAct=EBI-74615, EBI-2875665;
CC       Q9H0E2; P54253: ATXN1; NbExp=7; IntAct=EBI-74615, EBI-930964;
CC       Q9H0E2; Q9H305: CDIP1; NbExp=3; IntAct=EBI-74615, EBI-2876678;
CC       Q9H0E2; A8MTA8-2: CIMIP2B; NbExp=3; IntAct=EBI-74615, EBI-12160437;
CC       Q9H0E2; Q05048: CSTF1; NbExp=5; IntAct=EBI-74615, EBI-1789619;
CC       Q9H0E2; O75553: DAB1; NbExp=3; IntAct=EBI-74615, EBI-7875264;
CC       Q9H0E2; Q15038: DAZAP2; NbExp=11; IntAct=EBI-74615, EBI-724310;
CC       Q9H0E2; Q9UHG0: DCDC2; NbExp=3; IntAct=EBI-74615, EBI-10303987;
CC       Q9H0E2; Q14203-5: DCTN1; NbExp=3; IntAct=EBI-74615, EBI-25840379;
CC       Q9H0E2; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-74615, EBI-742054;
CC       Q9H0E2; Q86Y13: DZIP3; NbExp=2; IntAct=EBI-74615, EBI-948630;
CC       Q9H0E2; P19525: EIF2AK2; NbExp=2; IntAct=EBI-74615, EBI-640775;
CC       Q9H0E2; Q92567-2: FAM168A; NbExp=3; IntAct=EBI-74615, EBI-11978259;
CC       Q9H0E2; Q96NT3-2: GUCD1; NbExp=3; IntAct=EBI-74615, EBI-11978177;
CC       Q9H0E2; O43187: IRAK2; NbExp=2; IntAct=EBI-74615, EBI-447733;
CC       Q9H0E2; Q3SY46: KRTAP13-3; NbExp=5; IntAct=EBI-74615, EBI-10241252;
CC       Q9H0E2; Q3LI76: KRTAP15-1; NbExp=3; IntAct=EBI-74615, EBI-11992140;
CC       Q9H0E2; Q3SYF9: KRTAP19-7; NbExp=3; IntAct=EBI-74615, EBI-10241353;
CC       Q9H0E2; Q3LI64: KRTAP6-1; NbExp=5; IntAct=EBI-74615, EBI-12111050;
CC       Q9H0E2; Q3LI66: KRTAP6-2; NbExp=5; IntAct=EBI-74615, EBI-11962084;
CC       Q9H0E2; Q8IUC3: KRTAP7-1; NbExp=3; IntAct=EBI-74615, EBI-18394498;
CC       Q9H0E2; Q9H492: MAP1LC3A; NbExp=3; IntAct=EBI-74615, EBI-720768;
CC       Q9H0E2; Q5VYS4: MEDAG; NbExp=3; IntAct=EBI-74615, EBI-1050881;
CC       Q9H0E2; Q4VC12: MSS51; NbExp=3; IntAct=EBI-74615, EBI-11599933;
CC       Q9H0E2; P35548: MSX2; NbExp=3; IntAct=EBI-74615, EBI-6447480;
CC       Q9H0E2; Q14764: MVP; NbExp=3; IntAct=EBI-74615, EBI-2816254;
CC       Q9H0E2; Q16656-4: NRF1; NbExp=3; IntAct=EBI-74615, EBI-11742836;
CC       Q9H0E2; Q96HA8: NTAQ1; NbExp=4; IntAct=EBI-74615, EBI-741158;
CC       Q9H0E2; Q86TG7: PEG10; NbExp=2; IntAct=EBI-74615, EBI-2858265;
CC       Q9H0E2; Q9BSU1: PHAF1; NbExp=5; IntAct=EBI-74615, EBI-946080;
CC       Q9H0E2; O60260-5: PRKN; NbExp=3; IntAct=EBI-74615, EBI-21251460;
CC       Q9H0E2; Q86UA1: PRPF39; NbExp=3; IntAct=EBI-74615, EBI-2803203;
CC       Q9H0E2; P86480: PRR20D; NbExp=3; IntAct=EBI-74615, EBI-12754095;
CC       Q9H0E2; P20618: PSMB1; NbExp=3; IntAct=EBI-74615, EBI-372273;
CC       Q9H0E2; Q9NWB1-5: RBFOX1; NbExp=3; IntAct=EBI-74615, EBI-12123390;
CC       Q9H0E2; Q93062: RBPMS; NbExp=4; IntAct=EBI-74615, EBI-740322;
CC       Q9H0E2; Q9BQY4: RHOXF2; NbExp=6; IntAct=EBI-74615, EBI-372094;
CC       Q9H0E2; Q9Y3C5: RNF11; NbExp=3; IntAct=EBI-74615, EBI-396669;
CC       Q9H0E2; P37840: SNCA; NbExp=3; IntAct=EBI-74615, EBI-985879;
CC       Q9H0E2; Q9H668: STN1; NbExp=3; IntAct=EBI-74615, EBI-746930;
CC       Q9H0E2; O60784: TOM1; NbExp=8; IntAct=EBI-74615, EBI-74634;
CC       Q9H0E2; O60784-2: TOM1; NbExp=5; IntAct=EBI-74615, EBI-12117154;
CC       Q9H0E2; O75674: TOM1L1; NbExp=6; IntAct=EBI-74615, EBI-712991;
CC       Q9H0E2; O75674-2: TOM1L1; NbExp=5; IntAct=EBI-74615, EBI-12011552;
CC       Q9H0E2; Q6ZVM7: TOM1L2; NbExp=4; IntAct=EBI-74615, EBI-3452240;
CC       Q9H0E2; Q6ZVM7-2: TOM1L2; NbExp=7; IntAct=EBI-74615, EBI-12147805;
CC       Q9H0E2; Q8N5M4: TTC9C; NbExp=3; IntAct=EBI-74615, EBI-2851213;
CC       Q9H0E2; Q70EL1-9: USP54; NbExp=3; IntAct=EBI-74615, EBI-11975223;
CC       Q9H0E2; Q96S55: WRNIP1; NbExp=2; IntAct=EBI-74615, EBI-2513471;
CC       Q9H0E2; Q96E35: ZMYND19; NbExp=3; IntAct=EBI-74615, EBI-746595;
CC       Q9H0E2; Q9UGI0: ZRANB1; NbExp=3; IntAct=EBI-74615, EBI-527853;
CC       Q9H0E2-1; O60784: TOM1; NbExp=4; IntAct=EBI-16173683, EBI-74634;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:31263572}. Endosome
CC       {ECO:0000269|PubMed:15047686, ECO:0000269|PubMed:31263572}. Early
CC       endosome {ECO:0000269|PubMed:15047686, ECO:0000269|PubMed:26320582}.
CC       Note=Localized to endo/exosomal vesicles.
CC       {ECO:0000269|PubMed:31263572}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H0E2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H0E2-2; Sequence=VSP_056301;
CC   -!- DOMAIN: Both ATG8-interaction motifs (AIM1 and AIM2) are required for
CC       the association with ATG8 family proteins.
CC       {ECO:0000269|PubMed:25042851}.
CC   -!- DOMAIN: The N-terminal TOM1-binding domain (residues 1-53) is a
CC       disordered domain that partially folds when bound to the GAT domain of
CC       TOM1. {ECO:0000269|PubMed:26320582}.
CC   -!- PTM: Phosphorylated by IRAK1 upon stimulation by IL-1 or microbial
CC       products.
CC   -!- SIMILARITY: Belongs to the tollip family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14283.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ242972; CAB58118.1; -; mRNA.
DR   EMBL; AL136835; CAB66769.1; -; mRNA.
DR   EMBL; AK022871; BAB14283.1; ALT_INIT; mRNA.
DR   EMBL; AK127123; BAG54438.1; -; mRNA.
DR   EMBL; AC136297; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004420; AAH04420.1; -; mRNA.
DR   EMBL; BC012057; AAH12057.1; -; mRNA.
DR   EMBL; BC018272; AAH18272.1; -; mRNA.
DR   CCDS; CCDS7723.1; -. [Q9H0E2-1]
DR   CCDS; CCDS81532.1; -. [Q9H0E2-2]
DR   RefSeq; NP_001305441.1; NM_001318512.1.
DR   RefSeq; NP_001305443.1; NM_001318514.2. [Q9H0E2-2]
DR   RefSeq; NP_001305444.1; NM_001318515.1.
DR   RefSeq; NP_001305445.1; NM_001318516.1.
DR   RefSeq; NP_061882.2; NM_019009.3. [Q9H0E2-1]
DR   PDB; 1WGL; NMR; -; A=229-274.
DR   PDB; 2N31; NMR; -; A=1-53.
DR   PDBsum; 1WGL; -.
DR   PDBsum; 2N31; -.
DR   AlphaFoldDB; Q9H0E2; -.
DR   BMRB; Q9H0E2; -.
DR   SMR; Q9H0E2; -.
DR   BioGRID; 119978; 364.
DR   CORUM; Q9H0E2; -.
DR   DIP; DIP-30845N; -.
DR   FunCoup; Q9H0E2; 667.
DR   IntAct; Q9H0E2; 179.
DR   MINT; Q9H0E2; -.
DR   STRING; 9606.ENSP00000314733; -.
DR   GlyGen; Q9H0E2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9H0E2; -.
DR   MetOSite; Q9H0E2; -.
DR   PhosphoSitePlus; Q9H0E2; -.
DR   SwissPalm; Q9H0E2; -.
DR   BioMuta; TOLLIP; -.
DR   DMDM; 20140803; -.
DR   jPOST; Q9H0E2; -.
DR   MassIVE; Q9H0E2; -.
DR   PaxDb; 9606-ENSP00000314733; -.
DR   PeptideAtlas; Q9H0E2; -.
DR   ProteomicsDB; 3808; -.
DR   ProteomicsDB; 80260; -. [Q9H0E2-1]
DR   Pumba; Q9H0E2; -.
DR   Antibodypedia; 10168; 565 antibodies from 40 providers.
DR   DNASU; 54472; -.
DR   Ensembl; ENST00000317204.11; ENSP00000314733.5; ENSG00000078902.16. [Q9H0E2-1]
DR   Ensembl; ENST00000527886.5; ENSP00000434035.1; ENSG00000078902.16. [Q9H0E2-2]
DR   Ensembl; ENST00000707519.1; ENSP00000516890.1; ENSG00000291426.1. [Q9H0E2-1]
DR   Ensembl; ENST00000707520.1; ENSP00000516891.1; ENSG00000291426.1. [Q9H0E2-2]
DR   GeneID; 54472; -.
DR   KEGG; hsa:54472; -.
DR   MANE-Select; ENST00000317204.11; ENSP00000314733.5; NM_019009.4; NP_061882.2.
DR   UCSC; uc001ltd.4; human. [Q9H0E2-1]
DR   AGR; HGNC:16476; -.
DR   CTD; 54472; -.
DR   DisGeNET; 54472; -.
DR   GeneCards; TOLLIP; -.
DR   HGNC; HGNC:16476; TOLLIP.
DR   HPA; ENSG00000078902; Low tissue specificity.
DR   MIM; 606277; gene.
DR   OpenTargets; ENSG00000078902; -.
DR   VEuPathDB; HostDB:ENSG00000078902; -.
DR   eggNOG; ENOG502QWQA; Eukaryota.
DR   GeneTree; ENSGT00390000013104; -.
DR   HOGENOM; CLU_067725_2_0_1; -.
DR   InParanoid; Q9H0E2; -.
DR   OMA; IYIQIFD; -.
DR   OrthoDB; 9942608at2759; -.
DR   PAN-GO; Q9H0E2; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9H0E2; -.
DR   PathwayCommons; Q9H0E2; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   SignaLink; Q9H0E2; -.
DR   SIGNOR; Q9H0E2; -.
DR   BioGRID-ORCS; 54472; 12 hits in 1159 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; TOLLIP; human.
DR   EvolutionaryTrace; Q9H0E2; -.
DR   GeneWiki; TOLLIP; -.
DR   GenomeRNAi; 54472; -.
DR   Pharos; Q9H0E2; Tbio.
DR   PRO; PR:Q9H0E2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9H0E2; protein.
DR   Bgee; ENSG00000078902; Expressed in right frontal lobe and 184 other cell types or tissues.
DR   ExpressionAtlas; Q9H0E2; baseline and differential.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0019897; C:extrinsic component of plasma membrane; IC:UniProt.
DR   GO; GO:0016604; C:nuclear body; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:0005150; F:interleukin-1, type I receptor binding; IEA:Ensembl.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0060090; F:molecular adaptor activity; IDA:UniProt.
DR   GO; GO:0032183; F:SUMO binding; IEA:Ensembl.
DR   GO; GO:0035325; F:Toll-like receptor binding; IPI:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; IBA:GO_Central.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; IDA:UniProt.
DR   GO; GO:0045321; P:leukocyte activation; NAS:UniProtKB.
DR   GO; GO:0016310; P:phosphorylation; IDA:UniProtKB.
DR   GO; GO:0033235; P:positive regulation of protein sumoylation; IEA:Ensembl.
DR   GO; GO:0036010; P:protein localization to endosome; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IPI:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   CDD; cd04016; C2_Tollip; 1.
DR   CDD; cd14363; CUE_TOLIP; 1.
DR   FunFam; 1.10.8.10:FF:000036; Toll-interacting protein-like Protein; 1.
DR   FunFam; 2.60.40.150:FF:000055; Toll-interacting protein-like Protein; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   Gene3D; 1.10.8.10; DNA helicase RuvA subunit, C-terminal domain; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR003892; CUE.
DR   InterPro; IPR041799; TOLIP_CUE.
DR   InterPro; IPR037301; Tollip_C2.
DR   InterPro; IPR009060; UBA-like_sf.
DR   PANTHER; PTHR16461; TOLL-INTERACTING PROTEIN; 1.
DR   PANTHER; PTHR16461:SF5; TOLL-INTERACTING PROTEIN; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF02845; CUE; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00546; CUE; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF46934; UBA-like; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS51140; CUE; 1.
DR   neXtProt; NX_Q9H0E2; -.
DR   PharmGKB; PA134876213; -.
DR   TreeFam; TF324180; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Autophagy; Cytoplasm;
KW   Endosome; Immunity; Inflammatory response; Innate immunity; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..274
FT                   /note="Toll-interacting protein"
FT                   /id="PRO_0000072625"
FT   DOMAIN          35..152
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          229..272
FT                   /note="CUE"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00468"
FT   MOTIF           133..136
FT                   /note="AIM1"
FT   MOTIF           151..154
FT                   /note="AIM2"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   VAR_SEQ         1..69
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056301"
FT   VARIANT         161
FT                   /note="D -> N (in dbSNP:rs1037270334)"
FT                   /evidence="ECO:0000269|PubMed:26282398"
FT                   /id="VAR_079499"
FT   VARIANT         222
FT                   /note="A -> S (in dbSNP:rs5744015)"
FT                   /id="VAR_034557"
FT   MUTAGEN         9
FT                   /note="R->A: Reduced interaction with TOM1; when associated
FT                   with Ala-12."
FT                   /evidence="ECO:0000269|PubMed:26320582"
FT   MUTAGEN         12
FT                   /note="V->A: Reduced interaction with TOM1; when associated
FT                   with Ala-9."
FT                   /evidence="ECO:0000269|PubMed:26320582"
FT   MUTAGEN         20
FT                   /note="D->A: Reduced interaction with TOM1; when associated
FT                   with Ala-23."
FT                   /evidence="ECO:0000269|PubMed:26320582"
FT   MUTAGEN         21
FT                   /note="F->A: Reduced interaction with TOM1."
FT                   /evidence="ECO:0000269|PubMed:26320582"
FT   MUTAGEN         23
FT                   /note="R->A: Reduced interaction with TOM1; when associated
FT                   with Ala-20."
FT                   /evidence="ECO:0000269|PubMed:26320582"
FT   CONFLICT        40
FT                   /note="Missing (in Ref. 1; CAB58118)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        150
FT                   /note="K -> E (in Ref. 3; BAB14283)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..7
FT                   /evidence="ECO:0007829|PDB:2N31"
FT   STRAND          10..13
FT                   /evidence="ECO:0007829|PDB:2N31"
FT   HELIX           231..240
FT                   /evidence="ECO:0007829|PDB:1WGL"
FT   STRAND          242..244
FT                   /evidence="ECO:0007829|PDB:1WGL"
FT   HELIX           246..253
FT                   /evidence="ECO:0007829|PDB:1WGL"
FT   TURN            254..258
FT                   /evidence="ECO:0007829|PDB:1WGL"
FT   HELIX           260..269
FT                   /evidence="ECO:0007829|PDB:1WGL"
SQ   SEQUENCE   274 AA;  30282 MW;  386E0F284D3837DA CRC64;
     MATTVSTQRG PVYIGELPQD FLRITPTQQQ RQVQLDAQAA QQLQYGGAVG TVGRLNITVV
     QAKLAKNYGM TRMDPYCRLR LGYAVYETPT AHNGAKNPRW NKVIHCTVPP GVDSFYLEIF
     DERAFSMDDR IAWTHITIPE SLRQGKVEDK WYSLSGRQGD DKEGMINLVM SYALLPAAMV
     MPPQPVVLMP TVYQQGVGYV PITGMPAVCS PGMVPVALPP AAVNAQPRCS EEDLKAIQDM
     FPNMDQEVIR SVLEAQRGNK DAAINSLLQM GEEP
//
